Thema
Adalimumab
7.194
FYS6T7F842
Journal Article
6.059
Antibodies, Monoclonal, Humanized
3.560
Tumor Necrosis Factor-alpha
3.183
Infliximab
3.010
B72HH48FLU
3.005
Antibodies, Monoclonal
2.820
Antirheumatic Agents
2.271
Etanercept
1.912
OP401G7OJC
1.910
Research Support, Non-U.S. Gov't
1.863
Anti-Inflammatory Agents
1.646
Case Reports
1.484
Immunoglobulin G
1.170
Receptors, Tumor Necrosis Factor
1.127
Review
1.069
Letter
918
Methotrexate
733
YL5FZ2Y5U1
726
Multicenter Study
673
Biological Products
619
Comparative Study
589
Immunosuppressive Agents
565
Randomized Controlled Trial
539
Tumor Necrosis Factor Inhibitors
477
adalimumab
442
Ustekinumab
428
FU77B4U5Z0
427
Observational Study
415
Gastrointestinal Agents
362
Dermatologic Agents
353
Biosimilar Pharmaceuticals
312
golimumab
310
Certolizumab Pegol
308
UMD07X179E
308
91X1KLU43E
305
Comment
287
Systematic Review
272
Anti-Inflammatory Agents, Non-Steroidal
266
Immunologic Factors
252
Biomarkers
242
Meta-Analysis
235
Klinische Studie
210
Clinical Trial, Phase III
210
9007-41-4
207
C-Reactive Protein
207
Crohn’s disease
203
psoriasis
190
rheumatoid arthritis
168
mehr ...